MarketPeel
Insider Trading Intelligence
JK

John Kiely

AMRX
DIRECTOR · AMNEAL PHARMACEUTICALS, INC. · CIK 0001781149
FILING MIX · LIFETIME59%/41%
BUYS
16
SELLS
11
TOTAL VALUE
$997.5K
COMPANIES
1
ACTIVE SINCE
May 2020
HOLDINGS NOW
260,252
AVG SELL PX
$8.26
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by John Kiely, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%+2.22%+1.30%+0.92%-0.12%
14d4+50.00%+1.33%+2.46%-1.14%-1.56%
30d4+50.00%+2.16%+3.12%-0.96%+0.52%
60d4+25.00%+7.11%+6.31%+0.80%+1.53%
90d4+25.00%+9.65%+8.14%+1.51%-0.90%
180d4+25.00%+20.10%+11.09%+9.01%+11.33%
1y4(1 pending)+33.33%+45.12%+26.99%+18.14%+31.06%
2y4(3 pending)+0.00%-23.40%+37.32%-60.72%-60.72%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AMRX · 260,252 shares · as of May 7, 2026
076,858153,717230,575307,433202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 11 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
34,8190May 7, 2026May 8, 2026View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
34,819260,252May 7, 2026May 8, 2026View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,82419,824May 6, 2026May 8, 2026View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
32,000$9.23$295.4K225,433Aug 27, 2025Aug 28, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
50,000$7.59$379.5K257,433May 12, 2025May 13, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,81934,819May 6, 2025May 8, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
40,258307,433May 5, 2025May 8, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
40,2580May 5, 2025May 8, 2025View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
17,058$8.38$142.9K267,175Nov 22, 2024Nov 26, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
28,506$4.76$135.7K284,233Nov 22, 2024Nov 26, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
28,5060Nov 22, 2024Nov 26, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
76,453255,727May 10, 2024May 14, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
76,4530May 10, 2024May 14, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,25840,258May 2, 2024May 6, 2024View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
80,1280May 10, 2023May 11, 2023View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
80,128179,274May 10, 2023May 11, 2023View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
76,45376,453May 9, 2023May 11, 2023View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
80,12880,128May 9, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
35,4060May 8, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
35,40699,146May 8, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
46,2180May 6, 2021May 7, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
46,21863,740May 6, 2021May 7, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,40635,406May 5, 2021May 7, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
7,5220Dec 15, 2020Dec 18, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
7,52217,522Dec 15, 2020Dec 18, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
10,000$4.40$44.0K10,000May 19, 2020May 19, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
46,21846,218May 5, 2020May 6, 2020View →
Other insiders · AMRX
Loading peer insiders…
About this filer
CIK 0001781149
ROLE
Director
PRIMARY
AMRX
COMPANIES
1
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001781149DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback